Swertiamarin (P < 0.01) significantly up regulated mRNA as well as protein expression of StAR, CYP19A1, 17β-HSD and 3β-HSD and was equally potent to metformin in PCOS-IR. The gene discussed is CYP19A1; the disease is polycystic ovary syndrome.